V028-2927 Screening compound: N-[1-(3,4-dimethoxyphenyl)-4-phenyl-1H-imidazol-2-yl]-2-[N-(prop-2-en-1-yl)4-chlorobenzenesulfonamido]acetamide

V028-2927 Screening compound: N-[1-(3,4-dimethoxyphenyl)-4-phenyl-1H-imidazol-2-yl]-2-[N-(prop-2-en-1-yl)4-chlorobenzenesulfonamido]acetamide
V028-2927 Screening compound: N-[1-(3,4-dimethoxyphenyl)-4-phenyl-1H-imidazol-2-yl]-2-[N-(prop-2-en-1-yl)4-chlorobenzenesulfonamido]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V028-2927
N-[1-(3,4-dimethoxyphenyl)-4-phenyl-1H-imidazol-2-yl]-2-[N-(prop-2-en-1-yl)4-chlorobenzenesulfonamido]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V028-2927

Molecular Formula

C28H27ClN4O5S (C28 H27 ClN4 O5 S)

Compound Name

N-[1-(3,4-dimethoxyphenyl)-4-phenyl-1H-imidazol-2-yl]-2-[N-(prop-2-en-1-yl)4-chlorobenzenesulfonamido]acetamide

IUPAC name

N-[1-(34-dimethoxyphenyl)-4-phenyl-1H-imidazol-2-yl]-2-[N-(prop-2-en-1-yl)4-chlorobenzenesulfonamido]acetamide

SMILES

COc(ccc(-n1c(NC(CN(CC=C)S(c(cc2)ccc2Cl)(=O)=O)=O)nc(-c2ccccc2)c1)c1)c1OC

InChI

InChI=1S/C28H27ClN4O5S/c1-4-16-32(39(35,36)23-13-10-21(29)11-14-23)19-27(34)31-28-30-24(20-8-6-5-7-9-20)18-33(28)22-12-15-25(37-2)26(17-22)38-3/h4-15,17-18H,1,16,19H2,2-3H3,(H,30,31,34)

InChI Key

AZVQQUFIYRJIDP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19824778

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

567.07

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

5.474

Distribution Coefficient, logD

5.474

Water Solubility, LogSw

-5.96

Polar Surface Area

83.068

Acid Dissociation Constant (pKa)

12.45

Base Dissociation Constant (pKb)

2.52

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

14.30

V028-2927 in Drug Discovery

Included in Screening Libraries

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with V028-2927 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V028-2927?
Check Price and Availability of V028-2927, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V028-2927 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V028-2927
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V028-2927
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V028-2927 available by request